Order Article Reprints

Hoefnagel SJM, Koemans WJ, Khan HN, Koster J, Meijer SL, van Dieren JM, Kodach LL, van Sandick JW, Calpe S, del Sancho-Serra CM, et al. Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies. Cancers. 2022; 14(18):4498. https://doi.org/10.3390/cancers14184498

Hoefnagel, Sanne J. M., Willem J. Koemans, Hina N. Khan, Jan Koster, Sybren L. Meijer, Jolanda M. van Dieren, Liudmila L. Kodach, Johanna W. van Sandick, Silvia Calpe, Carmen M. del Sancho-Serra, and et al. 2022. "Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies" Cancers 14, no. 18: 4498. https://doi.org/10.3390/cancers14184498

Hoefnagel, S. J. M., Koemans, W. J., Khan, H. N., Koster, J., Meijer, S. L., van Dieren, J. M., Kodach, L. L., van Sandick, J. W., Calpe, S., del Sancho-Serra, C. M., Correia, A. C. P., Van Berge Henegouwen, M. I., Gisbertz, S. S., Hulshof, M. C. C. M., Mattioli, S., Spaander, M. C. W., & Krishnadath, K. K. (2022). Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies. Cancers, 14(18), 4498. https://doi.org/10.3390/cancers14184498